 |
|
Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population-based cross-sectional study
Jaejun Lee, Taeyun Kim, Hyun Yang, Si Hyun Bae
Clin Mol Hepatol. 2022;28(2):196-206. Published online 2022 Jan 13 DOI: https://doi.org/10.3350/cmh.2021.0371
|
|
Citations to this article as recorded by
 Prevalence of Non-alcoholic Fatty Liver Disease in Iran: A Systematic Review and Meta-analysis
Seidamir P. Tabaeian, Aziz Rezapour, Samad Azari, Mariano Martini, Maryam Saran, Meysam Behzadifar, Saeed Shahabi, Abdollah Sayyad, Ali Tahernejad, N.L. Bragazzi, S.J. Ehsanzadeh, Masoud Behzadifar
Journal of Clinical and Experimental Hepatology.2024; 14(1): 101209. CrossRef Impact of Overseas Deployment on Fatty Liver and Metabolic Diseases Among Korean Soldiers
Chang In Han, Jaejun Lee
Military Medicine.2024;[Epub] CrossRef Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non‐alcoholic fatty liver disease
Ho Soo Chun, Minjong Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong‐Ho Lee, Ji‐Hye Kim, Seung Up Kim
Liver International.2023; 43(3): 608. CrossRef Global incidence and prevalence of nonalcoholic fatty liver disease
Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah
Clinical and Molecular Hepatology.2023; 29(Suppl): S32. CrossRef Preventive effect of empagliflozin and ezetimibe on hepatic steatosis in adults and murine models
Dong Yun Kim, Kyu Sik Chung, Jun Yong Park, Heon Yung Gee
Biomedicine & Pharmacotherapy.2023; 161: 114445. CrossRef Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
Sara Battistella, Francesca D’Arcangelo, Marco Grasso, Alberto Zanetto, Martina Gambato, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra
Clinical and Molecular Hepatology.2023; 29(Suppl): S286. CrossRef Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
Yi-wen Shi, Jian-Gao Fan
Clinical and Molecular Hepatology.2023; 29(Suppl): S228. CrossRef Bariatric surgery for non-alcoholic fatty liver disease: Indications and post-operative management
Anja Geerts, Sander Lefere
Clinical and Molecular Hepatology.2023; 29(Suppl): S276. CrossRef The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
Hyunwoo Oh, Won Sohn, Yong Kyun Cho
Clinical and Molecular Hepatology.2023; 29(Suppl): S261. CrossRef Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017
Eugene Han, Kyung-Do Han, Yong-ho Lee, Kyung-Soo Kim, Sangmo Hong, Jung Hwan Park, Cheol-Young Park
Diabetes & Metabolism Journal.2023; 47(3): 347. CrossRef Low‐quality muscle mass rather than normal‐quality muscle mass determines fibrosis progression in biopsy‐proven NAFLD
Yun Kyu Lee, Bo Kyung Koo, Sae Kyung Joo, Dong Hyeon Lee, Heejoon Jang, Jee Won Chai, Myoung Seok Lee, Si Won Jang, Young Ho So, Jeong Hwan Park, Mee Soo Chang, Won Kim
Alimentary Pharmacology & Therapeutics.2023; 58(3): 322. CrossRef Analysis of risk factors related to nonalcoholic fatty liver disease: a retrospective study based on 31,718 adult Chinese individuals
Ganggang Wang, Xiaowei Shen, Yicun Wang, Huanhua Lu, Hua He, Xiaoliang Wang
Frontiers in Medicine.2023;[Epub] CrossRef A survey on the awareness, current management, and barriers for non-alcoholic fatty liver disease among the general Korean population
Jun-Hyuk Lee, Jang Han Jung, Huiyul Park, Joo Hyun Oh, Sang Bong Ahn, Eileen Laurel Yoon, Dae Won Jun
Scientific Reports.2023;[Epub] CrossRef Muscle Mass Adjusted for Body Weight Is Associated with Significant Liver Fibrosis in Young Adults with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study from a Korean Military Hospital
Jaejun Lee, Seongjoo Na, Taeyun Kim, Seong-Woo Lee, Myoung Jung Kim, Chang In Han, Si Hyun Bae
Journal of Obesity & Metabolic Syndrome.2023; 32(3): 279. CrossRef Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
Soon Sun Kim, Jae Youn Cheong
Clinical and Molecular Hepatology.2022; 28(4): 802. CrossRef
|